Trajan accelerating adoption and growth of microsampling technologies

Trajan accelerating adoption and growth of microsampling technologies

December 06, 2019

Melbourne, Victoria, Australia – 6 December 2019

Trajan Scientific and Medical (Trajan) announce the appointment of two new roles in their expanding Microsampling business to support global adoption of the portfolio. Led by Dr Anne Collins, the Microsampling business is focused on enabling samples that would not or could not otherwise be taken, to drive information-rich decision making.

The creation of two new roles at Trajan see Dr Florian Lapierre step into the role of Senior Product Specialist, and Pawanbir Singh M.D. as Business Development Manager - Microsampling, UK and Europe. Both roles highlight the evolution of the market and increased demand for patient centric microsampling technologies.

Dr Florian LapierreLocated in Fribourg, Switzerland, Dr Lapierre is responsible for strengthening the connection across functional departments within Trajan by supporting the growing market for microsampling, product knowledge, and assisting with needs for future product development.

Dr Lapierre joined Trajan in 2015 as a Research Scientist within ASTech (ARC Training Centre for Portable Analytical Separation Technologies); during this time he developed the initial hemaPEN® concept, and has been instrumental in the evolution of the technology.

Dr Pawanbir SinghUK-based Dr Singh, is a Medical Doctor who is responsible for developing commercialization blueprints and leading new technology adoption, support growing interest in patient centric sampling technologies.

Dr Singh joined Trajan in 2015 as Market Manager for Health, having previously worked for Leica Biosystems and STEMCELL Technologies.

Dr Collins said, “I’m excited to have Dr Lapierre and Dr Singh strengthen the team in their new roles, and have them focused on leading the technology adoption of Trajan’s portfolio including the hemaPEN technology platform.”

hemaPEN provides a convenient sampling procedure for collection and storage of four dried blood spot (DBS) samples to drive information-rich decision making. Unlike conventional DBS sampling tools, hemaPEN enables collection of an accurate and precise fixed micro-volume, and is designed to maintain sample integrity for quantitative analysis.

Stephen Tomisich, CEO advised that, “The technologies Trajan has developed have real potential to spark changes in approaches to healthcare that will truly deliver upon the Trajan vision - science that benefits people.”

To learn more about Trajan’s microsampling technologies and capabilities visit www.trajanscimed.com/microsampling.

Download
Press release [PDF]

More information
Microsampling
hemaPEN
ASTech

Media contact information
Trajan Scientific and Medical
Tel: +44 (0) 1908 568 844
media@trajanscimed.com

The hemaPEN® is a device supplied for research purposes only. This device is not for therapeutic or diagnostic use.

 




Also in News

Pens and prospering as a manufacturer
Pens and prospering as a manufacturer

November 18, 2019

Trajan Scientific and Medical has been featured by @AuManufacturing, highlighting Trajan's ongoing investment into the development of hemaPEN®, and other technologies to address emerging trends in healthcare.

Read More

Trajan strengthens their health business with appointment of Marco Baccanti
Trajan strengthens their health business with appointment of Marco Baccanti

July 18, 2019

Trajan Scientific and Medical has appointed Marco Baccanti as CEO of its joint venture in nutritional testing, Trajan Nutrition. Mr. Baccanti’s appointment strengthens Trajan Nutrition to accelerate the growth and impact of the work and research led by Trajan and professors Maria Makrides and Robert Gibson.

Read More

Research supports new wound care solutions
Research supports new wound care solutions

July 15, 2019

Not-for-profit health and aged care provider Bolton Clarke is taking the lead in prevention and early identification of evidence-based wound care with new research using narrow band imaging to detect problems early. The new project funded by Trajan Scientific and Medical, has a focus on leg wounds. The impact of chronic wounds is in the spotlight with Wound Awareness Week 15-21 July 2019.

Read More